World AIDS Day: HIV transmission shows no sign of declining in EuropeArchived
Marking World AIDS Day 2011, ECDC and the WHO Regional Office for Europe release today their joint publication HIV/AIDS surveillance in Europe 2010. The new data raises concern about the continuing transmission of HIV in Europe, as newly diagnosed HIV infections are still on the increase.
In 2010, 27.116 newly diagnosed HIV infections were reported across the European Union and the European Economic Area (EU/EEA) indicating an increase of around 4%. In contrast, the steady decrease of AIDS cases continued in 2010 with 4.666 reported cases in the EU/EEA region. This constitutes a decrease of nearly 50% in reported AIDS cases from 2004 to 2010.
The HIV epidemics are remarkably distinct in individual countries but overall HIV continues to disproportionally affect certain key populations, in particular men who have sex with men, persons originating from countries with generalised HIV epidemics and people who inject drugs.
ECDC has published a Guidance on HIV testingand the joint ECDC–EMCDDA Prevention and control of infectious diseases among people who inject drugs. Theseevidence-based guidance reports aim to assist in shaping effective national HIV/AIDS policies as both people who inject drugs as well as HIV positive persons who are unaware of their infection are main populations at risk for transmission of HIV.
Scientific meeting focuses on HIV and hepatitis prevention among people who inject drugs
On the eve of World AIDS Day 2011, ECDC and EMCDDA are organising a scientific seminar in the European Parliament with the aim to increase awareness of the ongoing HIV/AIDS epidemic and the burden of HIV-related infections in EU countries.
The focus of this year’s seminar will be HIV and hepatitis prevention among people who inject drugs. The ECDC and the EMCDDA will present their recent joint guidance Prevention and control of infectious diseases among people who inject drugs. Representatives of hepatitis B and C patients’ associations have also been invited to join the discussion.
Speaking at the seminar in Brussels, ECDC Director Marc Sprengerstressed: “We need to demonstrate the political courage to focus on key populations most affected by HIV and to address the issue of late diagnosis of HIV infection which often leads to delayed treatment and higher rates of AIDS-related morbidity and mortality. In this scenario, interventions to control the epidemic should be evidence-based and customised to the country and geographical area: only the knowledge of the characteristics of the epidemic in specific regions allows for effective responses.”
Director’s speech: 'Preventing HIV and viral Hepatitis infections among people who inject drugs'
- Joint ECDC WHO Europe HIV/AIDS surveillance in Europe 2010
- Joint EMCDDA-ECDC Report: Prevention and control of infectious diseases among people who inject drugs
- Joint EMCDDA-ECDC Report: Prevention and control of infectious diseases among people who inject drugs – Guidance in brief
- Guidance on HIV Testing: increasing uptake and effectiveness in the European Union (Guidance in brief, Evidence synthesis)
Evidence for the effectiveness of interventions to prevent infections among people who inject drugs:
- Part 1: Needle and syringe programmes and other interventions for preventing hepatitis C, HIV and injecting risk behaviour
- Part 2: Drug treatment for preventing hepatitis C, HIV and injecting risk behaviour
Half of all women with HIV are diagnosed late in Europe
28 Nov 2019 - Many women in the WHO European Region, particularly those in their 40s, are diagnosed at a late stage of HIV infection when their immune system is already starting to fail. They are three to four times more likely to be diagnosed late than younger women. According to data for 2018 released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe, women accounted for one-third of the 141 000 new HIV diagnoses in the Region, indicating that this population needs more attention in Europe's prevention and testing efforts.
Know your status: get tested during European Testing Week
22 Nov 2019 - On the way towards the Sustainable Development Goal (SDG) for health, Europe has one important battle to take on: reducing the proportion of those living with undiagnosed HIV and viral hepatitis. Current status in the EU/EEA: one in seven people living with HIV are unaware of their infection, up to four out of 5 people living with hepatitis B and three out of four people with hepatitis C infection have not yet been diagnosed.
Around half a million men who have sex with men in the EU need PrEP but cannot access it
11 Oct 2019 - This estimate on the “PrEP gap” in Europe was published in a paper in Eurosurveillance stating that 500 000 men who have sex with men in the European Union currently cannot access HIV pre-exposure prophylaxis (PrEP), despite being very likely to use it.